FDA Issues Mass Recall of Blood Pressure Medication Over Cancer Risk Concerns
The US Food and Drug Administration has ordered a massive recall of blood pressure medication due to potential contamination with a cancer-causing chemical. More than half a million bottles of the prescription drug prazosin hydrochloride have been pulled from pharmacies nationwide by Teva Pharmaceuticals USA and Amerisource Health Services, amid fears that they may contain N-nitrosamine impurities.
Prazosin is commonly used to treat high blood pressure, but it also has applications in treating nightmares related to post-traumatic stress disorder. Despite its established uses, the FDA has deemed the risk from contaminated prazosin capsules as "Class II," a classification that suggests there is significant concern for cancer-causing effects.
Nitrosamines are a class of chemicals known for their potential to cause cancer when exposed to humans through various means, including medication production and storage. The FDA's decision highlights a critical oversight in the manufacturing process, prompting swift action from regulators to safeguard patients' health.
Healthcare professionals should exercise caution when dispensing prazosin hydrochloride until further notice. Patients with prescriptions for this drug are urged to check their stockpiles immediately and follow any instructions provided by their healthcare providers or pharmacies regarding potential disposal of recalled products.
The US Food and Drug Administration has ordered a massive recall of blood pressure medication due to potential contamination with a cancer-causing chemical. More than half a million bottles of the prescription drug prazosin hydrochloride have been pulled from pharmacies nationwide by Teva Pharmaceuticals USA and Amerisource Health Services, amid fears that they may contain N-nitrosamine impurities.
Prazosin is commonly used to treat high blood pressure, but it also has applications in treating nightmares related to post-traumatic stress disorder. Despite its established uses, the FDA has deemed the risk from contaminated prazosin capsules as "Class II," a classification that suggests there is significant concern for cancer-causing effects.
Nitrosamines are a class of chemicals known for their potential to cause cancer when exposed to humans through various means, including medication production and storage. The FDA's decision highlights a critical oversight in the manufacturing process, prompting swift action from regulators to safeguard patients' health.
Healthcare professionals should exercise caution when dispensing prazosin hydrochloride until further notice. Patients with prescriptions for this drug are urged to check their stockpiles immediately and follow any instructions provided by their healthcare providers or pharmacies regarding potential disposal of recalled products.